4-nitrobenzylthioinosine has been researched along with Adverse Drug Event in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denich, D; Gärtner, F; Ohmle, B; Parmar, S; Pitterle, K; Seeringer, A; Stingl, JC; Syrovets, T | 1 |
1 other study(ies) available for 4-nitrobenzylthioinosine and Adverse Drug Event
Article | Year |
---|---|
Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells.
Topics: Adult; Antimetabolites, Antineoplastic; Cell Survival; Cells, Cultured; Cytarabine; Cytidine Deaminase; Drug-Related Side Effects and Adverse Reactions; Equilibrative Nucleoside Transporter 1; Exons; Female; Genotype; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Factors; Thioinosine; Young Adult | 2011 |